Ticker Details
TherapeuticsMD, Inc. TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
IPO Date:	October 31, 2011
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$24.54M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 3.29%
Avg Daily Range (30 D):	$0.05 | 2.22%
Avg Daily Range (90 D):	$0.07 | 3.04%

Institutional Daily Volume
Avg Daily Volume:	1.73M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	257
Avg Trade Size (Sh.) (30 D):	184
Avg Trade Size (Sh.) (90 D):	175

Institutional Trades
Total Institutional Trades:	1,122
Avg Institutional Trade:	$1.43M
Avg Institutional Trade (30 D):	$2.37M
Avg Institutional Trade (90 D):	$2.37M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	10.79K

News

Oct 3, 2024 @ 12:30 PM Sexual Wellness Market to Witness 4.7% CAGR by 203... Source: Globe Newswire

Apr 14, 2023 @ 4:00 PM All You Need to Know About TherapeuticsMD (TXMD) R... Source: Zacks Equity Research

Nov 15, 2022 @ 12:55 AM TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenu... Source: Zacks Equity Research

Nov 9, 2022 @ 10:45 PM Organogenesis (ORGO) Lags Q3 Earnings and Revenue ... Source: Zacks Equity Research

Sep 7, 2022 @ 9:16 AM Why Allena Pharmaceuticals Tumbled Over 30%; Here ... Source: Lisa Levin

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.02	$.01	$-.05
Diluted EPS	$.02	$.01	$-.05
Revenue	$3.35M	$.72M	$.89M
Gross Profit
Net Income / Loss	$.18M	$.1M	$-.62M
Operating Income / Loss	$-3.83M	$-.72M	$-1.55M
Cost of Revenue
Net Cash Flow	$2.67M	$.94M	$.37M
PE Ratio

Splits
May 09, 2022	1:50
Oct 03, 2011	1:100
Jul 27, 2009	3:1